Multiple-stage screening and mortality in the Multiple Risk Factor Intervention Trial

Clinical Trials

Volumn 1, Issue 2, 2004, Pages 148-161

  Eberly, Lynn e ^a   Neaton, James d ^a   Thomas, Avis j ^a   Dai, yu ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY DISEASE; FOLLOW UP; HUMAN; MALE; MASS SCREENING; MIDDLE AGED; MORTALITY; PATIENT SELECTION; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SURVIVAL RATE; UNITED STATES;

ADULT; CORONARY DISEASE; FOLLOW-UP STUDIES; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PATIENT SELECTION; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; SURVIVAL RATE; UNITED STATES;

EID: 33646381205     PISSN: 17407745     EISSN: None     Source Type: Journal    
DOI: 10.1191/1740774504cn018oa     Document Type: Article

References (42)

1. Ederer F., Church T.R., Mandel J.S. Sample sizes for prevention trials have been too small. Am J Epidemiol 1993; 137(7): 787-796.
2. Garcia-Carbonero R., Hidalgo M., Paz-Ares L., et al. Patient selection in high-dose chemotherapy trials: Relevance in high-risk breast cancer. J Clin Oncol 1997; 15(10): 3178-3184.
3. Smith P., Arnesen H. Mortality in non-consenters in a post-myocardial infarction trial. J Intern Med 1990; 228: 253-256.
4. Sesso H.D., Gaziano J.M., VanDenburgh M., et al. Comparison of baseline characteristics and mortality experience of participants and nonparticipants in a randomized clinical trial. Control Clin Trials 2002; 23: 686-702.
5. McGovern P.G., Pankow J.S., Shahar E., et al. Recent trends in acute coronary heart disease: Mortality, morbidity, medical care, risk factors. N Engl J Med 1996; 334(14): 884-890.
6. Multiple Risk Factor Intervention Trial Research Group. Multiple Risk Factor Intervention Trial: risk factor changes and mortality results. JAMA 1982; 248(12): 1465-1477.
7. Neaton J.D., Grimm R.H. Jr., Cutler J.A., for the MRFIT Research Group. Recruitment of participants for the Multiple Risk Factor Intervention Trial (MRFIT). Control Clin Trials 1987; 8(S): 41-53.
8. The Multiple Risk Factor Intervention Trial Research Group. Statistical design considerations in the NHLI Multiple Risk Factor Intervention Trial. J Chron Dis 1977; 30: 261-275.
9. Sherwin R., Kaelber C.T., Kezdi P., Kjelsberg M.O., Thomas H.E. Jr. The Multiple Risk Factor Intervention Trial (MRFIT): II. The development of the protocol. Prev Med 1981; 10(4): 426-442.
10. Benfari R.C. The Multiple Risk Factor Intervention Trial (MRFIT): III. The model for intervention. Prev Med 1981; 10(4): 426-442.
11. Multiple Risk Factor Intervention Trial Research Group. Mortality after 16 years for participants randomized to the Multiple Risk Factor Intervention Trial. Circ 1996; 94: 946-951.
12. Wentworth D., Neaton J.D., Rasmussen W. An evaluation of the Social Security Administration Master Beneficiary Record Index File and the National Death Index in the ascertainment of vital status. Am J Public Health 1983; 73: 1270-1274.
13. Boyle C.A., Decoufle P. National sources of vital status information: extent of coverage and possible selectivity in reporting. Am J Epidemiol 1990; 131(1): 160-168.
14. Calle EE., Terrell D.D. Utility of the National Death Index for ascertainment of mortality among Cancer Prevention Study II participants. Am J Epidemiol 1993; 137(2): 235-241.
15. Horm J. Assignment of probabilistic scores to National Death Index Record matches. Hyattsville, MD: National Center for Health Statistics, 1996.
16. Lash T.L., Silliman R.A. A comparison of the National Death Index and Social Security Administration databases to ascertain vital status. Epidemiol 2001; 12(2): 259-261.
17. No author listed. International Classification of Diseases, Ninth Revision, North American Clinical Modification, volume 1.Ann Arbor, MI: Edwards Brothers, Inc., 1981.
18. World Health Organization. International classification of diseases, tenth revision. Geneva: World Health Organization, 1992.
19. Sathiakumar N., Delzell E., Abdalla O. Using the National Death Index to obtain underlying cause of death codes. J Occ Environ Med 1998; 40(9): 808-813.
20. Doody M.M., Hayes H.M., Bilgrad R. Comparability of National Death Index Plus and standard procedures for determining causes of death in epidemiologic studies. Ann Epidemiol 2001; 11: 46-50.
21. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
22. Cox DR. Regression models and life tables with discussion. J R Stat Soc (Ser B) 1972; 34: 187-220.
23. Liang K.-Y., Zeger S.L. Longitudinaldataanalysis using generalized linear models. Biometrika 1986; 73: 13-22.
24. Rosengren A., Wilhelmsen L., Berglund G., Elmfeldt D. Non-participants in a general population study of men, with special reference to social and alcoholic problems. Acta Scan Med 1987; 221(3): 243-251.
25. Fosså S.D., Skovlund E. Selection of patients may limit the generalizability of results from cancer trials. Acta Oncologica 2002; 41(2): 131-137.
26. Antman K., Amato D., Wood W., et al. Selection bias in clinical trials. J Clin Oncol 1985; 3: 1142-1147.
27. Begg C.B., Engstrom P.F. Eligibility and extrapolation in cancer clinical trials. J Clin Oncol 1987; 5: 962-968.
28. Bj∅rn M., Brendstrup C., Karlsen S., Carlsen J.E. Consecutive screening and enrollment in clinical trials: the way to representative patient samples? J Cardiac Failure 1998; 4(3): 225-230.
29. Rahman Z.U., Frye D.K., Buzdar A.U., et al. Impact of selection process on response rate and long-term survival of potential high-dose doxorubicin-containing chemotherapy in patients with metastatic breast cancer. J Clin Oncol 1997; 15(10): 3171-3177.
30. Schor S.S., Clark T.W., Parkhurst L.W., Baker J.P., Elson K.A. Anevaluationoftheperiodichealth examination. Ann of Intern Med 1964; 61(6): 999-1005.
31. Roberts N.J., Ipsen J., Elson K.O., Clark T.W., Yanagawa H. Mortality among males in periodic-health-examination programs. New Engl J Med 1969; 281(1): 20-24.
32. Friedman G.D., Collen M.F., Fireman B.H. Multiphasic Health Checkup evaluation - A 16 year follow-up. J Chron Dis 1986; 39(6): 453-463.
33. Seltzer C.C., Jablon S. Effects of selection on mortality. Amer J Epid 1974; 100: 367-372.
34. Pablos-Mendez A., Barr R.G., Shea S. Run-in periods in randomized trials: implications for the application of results in clinical practice. JAMA 1998; 279: 222-225.
35. Yusuf S., Thom T, Abbott R.D. Changes in hypertension treatment and in congestive heart failure mortality in the United States. Hypertension 1989; 13(5 Suppl): 174-79.
36. Sytkowski P.A., Kannel W.B., D'Agostino R.B. Changes in risk factors and the decline in mortality from cardiovascular disease: The Framingham Heart Study. New Engl J Med 1990; 322(23): 1635-1641.
37. Gillum R.F. Trends in acute MI and coronary heart disease death in the United States. J Am Coll Cardiol 1994; 23: 1273-1277.
38. Massie B.M., Shah N.B. Evolving trends in the epidemiologic factors of heart failure: Rationale for preventive strategies and comprehensive disease management. Am Heart J 1997; 133: 703-712.
39. Centers for Disease Control, National Center for Health Statistics, Trends in Health and Aging, Mortality by underlying cause, age, sex. Accessed 01 Oct 2003 from: webappa.cdc.gov/wds/eng/ReportFolders/Rfview/explorerp.asp
40. Gordon T. and Kannel W.B. Section 1: Introduction and general background. In Kannel W.B., Gordon T. eds. The Framingham Study, An epidemiological investigation of cardiovascular disease. Washington DC, Department of Health, Education, and Welfare (National Institutes of Health); 1968, 1a-1j.
41. Gordon T. Section 2: Follow-up to the eighth examination. In Kannel W.B., Gordon T. eds. The Framingham Study, An epidemiological investigation of cardiovascular disease. Washington DC, Department of Health, Education, and Welfare (National Institutes of Health); 1968, 2a-2c.
42. McGee D. and Gordon T. Section 31: The results of the Framingham study applied to four other US-based epidemiologic studies of cardiovascular disease. In Kannel W.E., Gordon T. eds. The Framingham Study: an epidemiologic investigation of cardiovascular disease. Washington DC, Department of Health, Education, and Welfare, (National Institute of Health); 1976, 1-15, publication No 76-1083.